Drug-related infectious diseases indicator / EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon)    

Donner un avis Titre : Drug-related infectious diseases indicator Type de document : Document texte divers Auteurs : I. GIRAUDON ; L. WIESSING ; E. KALAMARA ; D. HEDRICH ; R. SIMON ; K. PALCZAK ; J. VICENTE Congrès : EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) Editeur : Lisbon : OEDT / EMCDDA Année de publication : 2015 Importance : 1 p. Langues : Anglais (eng) Mots-clés : Organismes OEDT Thésaurus TOXIBASE EPIDEMIOLOGIE DESCRIPTIVE ; INFECTION ; HEPATITE ; PRODUIT ILLICITE ; VIH ; PREVALENCE Thésaurus Géographique EUROPE Discipline : EPI Epidémiologie / Epidemiology Résumé : Drug-related infectious diseases (DRID) are among the most serious health consequences of drug use. The DRID indicator collects data on the extent of drug-related infections among people who inject drugs. This group is a key population affected by blood-borne viruses - primarily human immunodeficiency virus (HIV) and hepatitis C and B viruses (HCV and HBV) - which can be transmitted through sharing injection equipment and, to a lesser extent, through sexual contact. The DRID indicator is one of a set of five key epidemiological indicators that are used by the EMCDDA to facilitate data collection, analysis and reporting on key aspects of the prevalence, patterns and consequences of drug use in Europe. Domaine : Drogues illicites / Illicit drugs Sous-type de document : Poster Lien : http://www.emcdda.europa.eu/attachements.cfm/att_242451_EN_14_20years_DRID_Final [...] URL : http://emcdda.europa.eu/activities/key-indicators Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=76496

Documents numériques

EMCDDA_20years_DRID_Poster.pdf Adobe Acrobat PDF

Hepatitis C among drug users in Europe. Epidemiology, treatment and prevention / OEDT = EMCDDA  

Donner un avis Titre : Hepatitis C among drug users in Europe. Epidemiology, treatment and prevention Type de document : Rapport Auteurs : OEDT = EMCDDA ; M. HICKMAN, Editeur scientifique ; N. K. MARTIN, Editeur scientifique ; I. GIRAUDON ; L. WIESSING ; D. HEDRICH ; E. KALAMARA ; P. GRIFFITHS ; R. SIMON Editeur : Lisbon : OEDT / EMCDDA Année de publication : 2016 Autre Editeur : Luxembourg : Publications Office of the European Union Collection : Insights, ISSN 1606-1683 n°23 Importance : 97 p. Présentation : fig., tabl., graph. ISBN/ISSN/EAN : 978-92-9168-928-6 Langues : Anglais (eng) Mots-clés : Organismes OEDT Thésaurus TOXIBASE HEPATITE ; USAGER ; INJECTION ; INFECTION ; TRAITEMENT ; PREVENTION ; ANTIVIRAUX ; EPIDEMIOLOGIE ; PREVALENCE Thésaurus Géographique EUROPE Discipline : MAL Maladies infectieuses / Infectious diseases Résumé : FRANÇAIS : L'hépatite C est une maladie infectieuse du foie causée par le virus de l'hépatite C (VHC) qui peut être transmis par le sang. Environ 115 millions de personnes à travers le monde ont été infectées à un moment donné de leur vie par le VHC. On estime que deux tiers de ces personnes sont infectées de manière chronique, dont plus de cinq millions au sein de l'Union européenne. L'infection est très répandue chez les usagers de drogue par injection, qui peuvent contracter le VHC par le partage de seringues et autre matériel d'injection. Dans ce rapport publié à l'occasion de la Journée mondiale contre l'hépatite, l'Observatoire européen des drogues et toxicomanies (EMCDDA) examine de nouvelles possibilités de prévention et de traitement efficaces de la maladie, notamment l'utilisation de nouvelles générations de médicaments. [Extrait du communiqué de presse] ENGLISH: Hepatitis C among drug users in Europe: epidemiology, treatment and prevention provides a timely contribution to raising awareness of the hepatitis C epidemic in Europe and the opportunities now opening up to tackle this problem decisively. A state of the art review of the epidemiology of hepatitis C virus (HCV) infection in Europe and an overview of the way preventive measures are currently implemented in European countries set the scene. International experts address the treatment of HCV infection among people who inject drugs, with an emphasis on how we encourage uptake and deliver effective outcomes. Implementation issues are also explored, as are the complementary roles of treatment and prevention. The new medicines and treatment regimens driving the transformation in the HCV treatment landscape are reviewed in detail. The challenges of scaling up HCV treatment and successfully involving drug using patients is explored from different viewpoints, including that of the drug user. Note de contenu : TABLE OF CONTENTS: Introduction. Chapter 1: Hepatitis C virus infection among people who inject drugs. Chapter 2: Treatment of hepatitis C virus infection among people who inject drugs. Chapter 3: Strategies to improve hepatitis C care and to enhance treatment uptake and adherence. Chapter 4: Hepatitis C prevention among people who inject drugs. Chapter 5: Antiviral medications for hepatitis C virus infection. Chapter 6: Scaling up hepatitis C treatment. Chapter 7: A framework for evaluating scale-up of hepatitis C virus treatment as prevention for people who inject drugs. Conclusions. Domaine : Drogues illicites / Illicit drugs Affiliation : School of Social and Community Medicine, University of Bristol, UK Cote : OEDT-7.23 Lien : http://www.emcdda.europa.eu/publications/insights/hepatitis-c-among-drug-users-i [...] Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=77489

Documents numériques

EMCDDA_Insights23_2016.pdf Adobe Acrobat PDF

EMCDDA_Insights23_CP20160728.pdf Adobe Acrobat PDF

Human immunodeficiency virus among people who inject drugs: Is risk increasing in Europe? / D. HEDRICH ; E. KALAMARA ; O. SFETCU ; A. PHARRIS ; A. NOOR ; L. WIESSING ; V. HOPE ; M. J. VAN DE LAAR in Eurosurveillance, Vol.18, n°48 (28 November 2013)  

Donner un avis [article]  inEurosurveillance > Vol.18, n°48 (28 November 2013) . - Art. 20648 Titre : Human immunodeficiency virus among people who inject drugs: Is risk increasing in Europe? Type de document : Périodique Auteurs : D. HEDRICH ; E. KALAMARA ; O. SFETCU ; A. PHARRIS ; A. NOOR ; L. WIESSING ; V. HOPE ; M. J. VAN DE LAAR Année de publication : 2013 Article en page(s) : Art. 20648 Langues : Anglais (eng) Mots-clés : Thésaurus Géographique EUROPE ; UNION EUROPEENNE Thésaurus TOXIBASE VIH ; USAGER ; INJECTION ; EVOLUTION ; PREVALENCE ; FACTEUR DE RISQUE ; CONTAMINATION Organismes OEDT Discipline : MAL Maladies infectieuses / Infectious diseases Résumé : In most European Union (EU)/European Economic Area (EEA) countries, between 2010 and 2012, reports of new human immunodeficiency virus (HIV) diagnoses among people who inject drugs have been stable or declining. HIV outbreaks in Greece and Romania, first reported in 2011, continue and economic conditions hinder provision of effective response coverage. When measured against some established thresholds, prevention coverage remains inadequate in at least one-third of EU/EEA countries. Urgent consideration to scale up prevention efforts is merited. Domaine : Drogues illicites / Illicit drugs Refs biblio. : 20 Affiliation : European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal Lien : http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20648 Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=73490 [article]

Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study / L. WIESSING ; M. FERRI ; V. BELACKOVA ; P. CARRIERI ; S. R. FRIEDMAN ; C. FOLCH ; K. DOLAN ; B. GALVIN ; P. VICKERMAN ; J. V. LAZARUS ; V. MRAVCIK ; M. KRETZSCHMAR ; V. SYPSA ; A. SARASA-RENEDO ; A. UUSKULA ; D. PARASKEVIS ; L. MENDAO ; D. ROSSI ; N. VAN GELDER ; L. MITCHESON ; L. PAOLI ; C. DIAZ GOMEZ ; M. MILHET ; N. DASCALU ; J. KNIGHT ; G. HAY ; E. KALAMARA ; R. SIMON ; C. COMISKEY ; C. ROSSI ; P. GRIFFITHS ; EUBEST working group in Harm Reduction Journal, Vol.14, n°19 (2017)  

Donner un avis [article]  inHarm Reduction Journal > Vol.14, n°19 (2017) . - 14 p. Titre : Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study Type de document : Périodique Auteurs : L. WIESSING ; M. FERRI ; V. BELACKOVA ; P. CARRIERI ; S. R. FRIEDMAN ; C. FOLCH ; K. DOLAN ; B. GALVIN ; P. VICKERMAN ; J. V. LAZARUS ; V. MRAVCIK ; M. KRETZSCHMAR ; V. SYPSA ; A. SARASA-RENEDO ; A. UUSKULA ; D. PARASKEVIS ; L. MENDAO ; D. ROSSI ; N. VAN GELDER ; L. MITCHESON ; L. PAOLI ; C. DIAZ GOMEZ ; M. MILHET ; N. DASCALU ; J. KNIGHT ; G. HAY ; E. KALAMARA ; R. SIMON ; C. COMISKEY ; C. ROSSI ; P. GRIFFITHS ; EUBEST working group Année de publication : 2017 Article en page(s) : 14 p. Langues : Anglais (eng) Mots-clés : Thésaurus TOXIBASE REDUCTION DES RISQUES ; INJECTION ; VIH ; HEPATITE ; EPIDEMIOLOGIE DESCRIPTIVE ; INTERVENTION ; QUALITE ; PRODUIT ILLICITE Thésaurus Géographique UNION EUROPEENNE ; EUROPE Mots-clés : bonnes pratiques  evidence-based Discipline : TRA Traitement et prise en charge / Treatment and care Résumé : Background and aims: Despite advances in our knowledge of effective services for people who use drugs over the last decades globally, coverage remains poor in most countries, while quality is often unknown. This paper aims to discuss the historical development of successful epidemiological indicators and to present a framework for extending them with additional indicators of coverage and quality of harm reduction services, for monitoring and evaluation at international, national or subnational levels. The ultimate aim is to improve these services in order to reduce health and social problems among people who use drugs, such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection, crime and legal problems, overdose (death) and other morbidity and mortality. Methods and results: The framework was developed collaboratively using consensus methods involving nominal group meetings, review of existing quality standards, repeated email commenting rounds and qualitative analysis of opinions/experiences from a broad range of professionals/experts, including members of civil society and organisations representing people who use drugs. Twelve priority candidate indicators are proposed for opioid agonist therapy (OAT), needle and syringe programmes (NSP) and generic cross-cutting aspects of harm reduction (and potentially other drug) services. Under the specific OAT indicators, priority indicators included 'coverage', 'waiting list time', 'dosage' and 'availability in prisons'. For the specific NSP indicators, the priority indicators included 'coverage', 'number of needles/syringes distributed/collected', 'provision of other drug use paraphernalia' and 'availability in prisons'. Among the generic or cross-cutting indicators the priority indicators were 'infectious diseases counselling and care', 'take away naloxone', 'information on safe use/sex' and 'condoms'. We discuss conditions for the successful development of the suggested indicators and constraints (e.g. funding, ideology). We propose conducting a pilot study to test the feasibility and applicability of the proposed indicators before their scaling up and routine implementation, to evaluate their effectiveness in comparing service coverage and quality across countries. Conclusions: The establishment of an improved set of validated and internationally agreed upon best practice indicators for monitoring harm reduction service will provide a structural basis for public health and epidemiological studies and support evidence and human rights-based health policies, services and interventions. Domaine : Drogues illicites / Illicit drugs Refs biblio. : 171 Affiliation : European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Lien : http://dx.doi.org/10.1186/s12954-017-0141-6 Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=78849 [article]

Problem drug use indicator / EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon)    

Donner un avis Titre : Problem drug use indicator Type de document : Document texte divers Auteurs : D. THANKI ; E. KALAMARA ; A. NOOR ; L. MONTANARI ; J. VICENTE Congrès : EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) Editeur : Lisbon : OEDT / EMCDDA Année de publication : 2015 Importance : 1 p. Langues : Anglais (eng) Mots-clés : Organismes OEDT Thésaurus TOXIBASE EPIDEMIOLOGIE DESCRIPTIVE ; USAGE PROBLEMATIQUE ; PREVALENCE ; PRODUIT ILLICITE Thésaurus Géographique EUROPE Discipline : EPI Epidémiologie / Epidemiology Résumé : Some drug users go on to develop more severe forms of use, defined by the EMCDDA as 'high-risk drug use': 'recurrent drug use that is causing actual harms (negative consequences) to the person (including dependence, but also other health, psychological or social problems) or is placing the person at a high probability/risk of suffering such harms'. In practice, data are collected through the Problem drug use (PDU) indicator on those whose consumption of drugs in the last 12 months is characterised by high-risk patterns of use or routes of administration. The PDU indicator is one of a set of five key epidemiological indicators that are used by the EMCDDA to facilitate data collection, analysis and reporting on key aspects of the prevalence and consequences of drug use. Domaine : Drogues illicites / Illicit drugs Sous-type de document : Poster Lien : http://www.emcdda.europa.eu/attachements.cfm/att_242449_EN_11_20years_PDU_Final. [...] URL : http://emcdda.europa.eu/activities/key-indicators Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=76493

Documents numériques

EMCDDA_20years_PDU_Poster.pdf Adobe Acrobat PDF